vs
科迪华（CTVA）与Ovintiv Inc.（OVV）财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是Ovintiv Inc.的1.9倍（$3.9B vs $2.1B），Ovintiv Inc.净利率更高（46.1% vs -14.1%，领先60.2%），科迪华同比增速更快（-1.7% vs -6.0%），科迪华自由现金流更多（$4.2B vs $489.0M），过去两年科迪华的营收复合增速更高（-6.7% vs -7.2%）
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
Ovintiv Inc.是一家总部位于美国丹佛的石油企业，前身为加拿大能源公司Encana，于2020年通过重组正式成立，主营石油、天然气的勘探、开发与生产业务，在北美能源领域拥有丰富的运营经验及市场积累。
CTVA vs OVV — 直观对比
营收规模更大
CTVA
是对方的1.9倍
$2.1B
营收增速更快
CTVA
高出4.3%
-6.0%
净利率更高
OVV
高出60.2%
-14.1%
自由现金流更多
CTVA
多$3.7B
$489.0M
两年增速更快
CTVA
近两年复合增速
-7.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.9B | $2.1B |
| 净利润 | $-552.0M | $946.0M |
| 毛利率 | 42.4% | — |
| 营业利润率 | -13.6% | 21.2% |
| 净利率 | -14.1% | 46.1% |
| 营收同比 | -1.7% | -6.0% |
| 净利润同比 | -1246.3% | 1676.7% |
| 每股收益（稀释后） | $-0.80 | $3.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTVAOVV
| Q4 25 | $3.9B | $2.1B | ||
| Q3 25 | $2.6B | $2.0B | ||
| Q2 25 | $6.5B | $2.2B | ||
| Q1 25 | $4.4B | $2.4B | ||
| Q4 24 | $4.0B | $2.2B | ||
| Q3 24 | $2.3B | $2.2B | ||
| Q2 24 | $6.1B | $2.2B | ||
| Q1 24 | $4.5B | $2.4B |
净利润CTVAOVV
| Q4 25 | $-552.0M | $946.0M | ||
| Q3 25 | $-320.0M | $148.0M | ||
| Q2 25 | $1.3B | $307.0M | ||
| Q1 25 | $652.0M | $-159.0M | ||
| Q4 24 | $-41.0M | $-60.0M | ||
| Q3 24 | $-524.0M | $507.0M | ||
| Q2 24 | $1.1B | $340.0M | ||
| Q1 24 | $419.0M | $338.0M |
毛利率CTVAOVV
| Q4 25 | 42.4% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 54.6% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 52.3% | — | ||
| Q1 24 | 43.2% | — |
营业利润率CTVAOVV
| Q4 25 | -13.6% | 21.2% | ||
| Q3 25 | -14.1% | 13.5% | ||
| Q2 25 | 27.9% | 23.1% | ||
| Q1 25 | 17.7% | -3.7% | ||
| Q4 24 | 2.2% | 0.1% | ||
| Q3 24 | -27.2% | 24.2% | ||
| Q2 24 | 21.9% | 25.4% | ||
| Q1 24 | 10.7% | 20.7% |
净利率CTVAOVV
| Q4 25 | -14.1% | 46.1% | ||
| Q3 25 | -12.2% | 7.3% | ||
| Q2 25 | 20.4% | 13.9% | ||
| Q1 25 | 14.8% | -6.7% | ||
| Q4 24 | -1.0% | -2.7% | ||
| Q3 24 | -22.5% | 23.3% | ||
| Q2 24 | 17.2% | 15.5% | ||
| Q1 24 | 9.3% | 14.2% |
每股收益（稀释后）CTVAOVV
| Q4 25 | $-0.80 | $3.64 | ||
| Q3 25 | $-0.47 | $0.57 | ||
| Q2 25 | $1.92 | $1.18 | ||
| Q1 25 | $0.95 | $-0.61 | ||
| Q4 24 | $-0.05 | $-0.22 | ||
| Q3 24 | $-0.76 | $1.92 | ||
| Q2 24 | $1.51 | $1.27 | ||
| Q1 24 | $0.60 | $1.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $280.0M |
| 总债务越低越好 | $1.7B | $5.2B |
| 股东权益账面价值 | $24.1B | $11.2B |
| 总资产 | $42.8B | $20.4B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.46× |
8季度趋势，按日历期对齐
现金及短期投资CTVAOVV
| Q4 25 | $4.5B | $280.0M | ||
| Q3 25 | $2.6B | $25.0M | ||
| Q2 25 | $2.1B | $20.0M | ||
| Q1 25 | $2.0B | $8.0M | ||
| Q4 24 | $3.2B | $42.0M | ||
| Q3 24 | $2.5B | $9.0M | ||
| Q2 24 | $2.0B | $8.0M | ||
| Q1 24 | $1.7B | $5.0M |
总债务CTVAOVV
| Q4 25 | $1.7B | $5.2B | ||
| Q3 25 | $1.7B | $5.2B | ||
| Q2 25 | $1.7B | $5.3B | ||
| Q1 25 | $1.8B | $5.5B | ||
| Q4 24 | $2.0B | $5.5B | ||
| Q3 24 | $2.0B | $5.9B | ||
| Q2 24 | $2.5B | $6.1B | ||
| Q1 24 | $2.5B | $6.2B |
股东权益CTVAOVV
| Q4 25 | $24.1B | $11.2B | ||
| Q3 25 | $25.2B | $10.2B | ||
| Q2 25 | $25.9B | $10.4B | ||
| Q1 25 | $24.3B | $10.1B | ||
| Q4 24 | $23.8B | $10.3B | ||
| Q3 24 | $24.7B | $10.7B | ||
| Q2 24 | $25.2B | $10.3B | ||
| Q1 24 | $24.8B | $10.3B |
总资产CTVAOVV
| Q4 25 | $42.8B | $20.4B | ||
| Q3 25 | $42.2B | $19.4B | ||
| Q2 25 | $41.8B | $19.7B | ||
| Q1 25 | $42.1B | $19.6B | ||
| Q4 24 | $40.8B | $19.3B | ||
| Q3 24 | $41.9B | $19.9B | ||
| Q2 24 | $41.5B | $19.8B | ||
| Q1 24 | $43.6B | $19.8B |
负债/权益比CTVAOVV
| Q4 25 | 0.07× | 0.46× | ||
| Q3 25 | 0.07× | 0.51× | ||
| Q2 25 | 0.07× | 0.51× | ||
| Q1 25 | 0.07× | 0.55× | ||
| Q4 24 | 0.08× | 0.53× | ||
| Q3 24 | 0.08× | 0.55× | ||
| Q2 24 | 0.10× | 0.59× | ||
| Q1 24 | 0.10× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4B | $954.0M |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $489.0M |
| 自由现金流率自由现金流/营收 | 106.2% | 23.8% |
| 资本支出强度资本支出/营收 | 5.7% | 22.6% |
| 现金转化率经营现金流/净利润 | — | 1.01× |
| 过去12个月自由现金流最近4个季度 | $2.8B | $1.5B |
8季度趋势，按日历期对齐
经营现金流CTVAOVV
| Q4 25 | $4.4B | $954.0M | ||
| Q3 25 | $193.0M | $812.0M | ||
| Q2 25 | $947.0M | $1.0B | ||
| Q1 25 | $-2.1B | $873.0M | ||
| Q4 24 | $4.2B | $1.0B | ||
| Q3 24 | $130.0M | $1.0B | ||
| Q2 24 | $451.0M | $1.0B | ||
| Q1 24 | $-2.6B | $659.0M |
自由现金流CTVAOVV
| Q4 25 | $4.2B | $489.0M | ||
| Q3 25 | $36.0M | $268.0M | ||
| Q2 25 | $829.0M | $492.0M | ||
| Q1 25 | $-2.2B | $256.0M | ||
| Q4 24 | $4.0B | $468.0M | ||
| Q3 24 | $-24.0M | $484.0M | ||
| Q2 24 | $337.0M | $398.0M | ||
| Q1 24 | $-2.8B | $68.0M |
自由现金流率CTVAOVV
| Q4 25 | 106.2% | 23.8% | ||
| Q3 25 | 1.4% | 13.3% | ||
| Q2 25 | 12.8% | 22.2% | ||
| Q1 25 | -49.9% | 10.8% | ||
| Q4 24 | 100.4% | 21.4% | ||
| Q3 24 | -1.0% | 22.2% | ||
| Q2 24 | 5.5% | 18.1% | ||
| Q1 24 | -61.4% | 2.8% |
资本支出强度CTVAOVV
| Q4 25 | 5.7% | 22.6% | ||
| Q3 25 | 6.0% | 26.9% | ||
| Q2 25 | 1.8% | 23.5% | ||
| Q1 25 | 2.1% | 26.0% | ||
| Q4 24 | 4.6% | 25.3% | ||
| Q3 24 | 6.6% | 24.7% | ||
| Q2 24 | 1.9% | 28.4% | ||
| Q1 24 | 3.3% | 24.8% |
现金转化率CTVAOVV
| Q4 25 | — | 1.01× | ||
| Q3 25 | — | 5.49× | ||
| Q2 25 | 0.72× | 3.30× | ||
| Q1 25 | -3.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.02× | ||
| Q2 24 | 0.43× | 3.00× | ||
| Q1 24 | -6.23× | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
OVV
| Product And Service Revenue | $1.7B | 84% |
| Sales Of Purchased Product | $338.0M | 16% |
